Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S, Parissis JT, Georgiadis M, Karatzas D, Paraskevaidis J, Kroupis C, Karavolias G, Koniavitou K, Kremastinos DT. Adamopoulos S, et al. Among authors: paraskevaidis j. Am Heart J. 2002 Aug;144(2):359-64. doi: 10.1067/mhj.2002.124052. Am Heart J. 2002. PMID: 12177657 Clinical Trial.
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT. Adamopoulos S, et al. Among authors: paraskevaidis j. J Am Coll Cardiol. 2002 Feb 20;39(4):653-63. doi: 10.1016/s0735-1097(01)01795-8. J Am Coll Cardiol. 2002. PMID: 11849865 Free article. Clinical Trial.
Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
Parissis JT, Adamopoulos S, Karatzas D, Paraskevaidis J, Livanis E, Kremastinos D. Parissis JT, et al. Among authors: paraskevaidis j. Eur J Cardiovasc Prev Rehabil. 2005 Apr;12(2):164-8. doi: 10.1097/01.hjr.0000159320.70090.3d. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 15785303 Clinical Trial.